Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company profileJeil Pharmaceutical

Access the most comprehensive report about Jeil Pharmaceutical available on the market

Buy Now

Data Insights

JPI-289 is under clinical development by Jeil Pharmaceutical and currently in Phase II for Myocardial Infarction. According to GlobalData, Phase...

Data Insights

JLP-2004 is under clinical development by Jeil Pharmaceutical and currently in Phase I for Osteoarthritis. According to GlobalData, Phase I...

Data Insights

JLP-2004 is under clinical development by Jeil Pharmaceutical and currently in Phase I for Rheumatoid Arthritis. According to GlobalData, Phase...

Data Insights

JLP-2004 is under clinical development by Jeil Pharmaceutical and currently in Phase I for Back Pain. According to GlobalData, Phase...